Invesco NASDAQ Biotechnology ETF
IBBQ
18 hedge funds and large institutions have $8.87M invested in Invesco NASDAQ Biotechnology ETF in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
2.95% less ownership
Funds ownership: 25.22% → 22.27% (-3%)
8% less capital invested
Capital invested by funds: $9.66M → $8.87M (-$792K)
14% less funds holding
Funds holding: 21 → 18 (-3)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCG
Breakwater Capital Group
Paramus,
New Jersey
|
+$510K |
| 2 |
PCIG
Partners Capital Investment Group
Boston,
Massachusetts
|
+$287K |
| 3 |
CW
CreativeOne Wealth
Overland Park,
Kansas
|
+$233K |
| 4 |
Morgan Stanley
New York
|
+$68.1K |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$14.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Raymond James Financial
St Petersburg,
Florida
|
-$888K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$314K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$230K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$216K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$80.7K |
IBBQ Hedge Fund Activity: Q1 2025 in Review
18 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q1 2025, worth a combined $8.87M — down 8.2% from $9.66M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of IBBQ and 3 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 6 added.
The largest buyer was Breakwater Capital Group, opening a new position worth an estimated $510K. The largest seller was Raymond James Financial, exiting entirely with an estimated $888K sold.
- 18 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q1 2025, down from 21 in Q4 2024.
- Funds reported $8.87M of Invesco NASDAQ Biotechnology ETF stock for Q1 2025, down 8.2% quarter-over-quarter.
- 3 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q1 2025 and 4 closed out, a net change of -1 holder.
- The largest Invesco NASDAQ Biotechnology ETF buyer in Q1 2025 was Breakwater Capital Group, an estimated $510K added.
- The largest Invesco NASDAQ Biotechnology ETF seller in Q1 2025 was Raymond James Financial, an estimated $888K sold.
Based on aggregated 13F filings for Q1 2025.